Artificial intelligence could be new blueprint for precision drug discovery
The Pharma Data
JULY 12, 2021
The AI approach helps model a disease using a map of successive changes in gene expression at the onset and during the progression of the disease. The underlying algorithms ensure that the identified gene expression patterns are ‘invariant’ regardless of different disease cohorts.
52 
Let's personalize your content